Fuad El-Hibri

CIK 1380185 · Chairman · last filed 2021-12-07

Fuad El-Hibri is a Chairman who has filed 157 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for EBS, was dated Dec 7, 2021. Across all open-market trades the lifetime net is −$115.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.4M across reported positions. 144 SEC filings were submitted jointly with Emergent BioSolutions Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.37M

Companies

2

Total Filings

157

Lifetime Open-Market Net

-$115.13M

Filer Profile

Reported Address
2273 RESEARCH BLVD, SUITE 400
ROCKVILLE, MD 20850
Related Filers
Emergent BioSolutions Inc. — 144 joint filings, latest 2021-12-07
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EBS Chairman 1,343,405 $6.23 $8.37M -$115.38M 139 2021-12-07
APVO Director 0 $1.82 $0 $248.2K 18 2021-12-07

Recent Filings

157 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-12-07 EBS Other (J) +3,500,008 $0 EDGAR
2021-12-07 APVO Other (J) +124,999 $0 EDGAR
2021-06-02 APVO Grant (A) $0 EDGAR
2021-02-26 EBS Grant (A) $0 EDGAR
2021-02-17 APVO Grant (A) $0 EDGAR
2020-11-12 EBS Mixed -$2.57M EDGAR
2020-11-04 EBS Mixed -$2.57M EDGAR
2020-09-25 EBS Sell (S) −25,535 -$2.55M EDGAR
2020-09-18 EBS Sell (S) −40,000 -$4.06M EDGAR
2020-09-11 EBS Sell (S) −40,000 -$4.11M EDGAR
Showing 110 of 157
Page 1 of 16
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.